We are live on ! Find out more
OSRHW

OSR Health Warrant
OSRHW

26 hedge funds and large institutions have $3.51M invested in OSR Health Warrant in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 2826 (-2)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

38% less capital invested

Capital invested by funds: $5.65M → $3.51M (-$2.14M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WC
26
Wealthspring Capital
New York
$310
MP
27
Mangrove Partners
Connecticut
-$2.2M -204,072 Closed
EAM
28
Exos Asset Management
New York
-$4K -200,000 Closed
KPF
29
K2 Principal Fund
Ontario, Canada
-$246 -12,317 Closed
FTUS
30
Flow Traders U.S.
New York
-$118 -3,144 -16%

OSRHW Hedge Fund Activity: Q3 2024 in Review

26 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q3 2024, worth a combined $3.51M — down 38% from $5.65M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of OSRHW and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Cowen and Company, adding an estimated $15.1K. The largest seller was Mangrove Partners, exiting entirely with an estimated $2.2M sold.

  • 26 institutional investors held OSR Health Warrant (OSRHW) as of Q3 2024, down from 28 in Q2 2024.
  • Funds reported $3.51M of OSR Health Warrant stock for Q3 2024, down 38% quarter-over-quarter.
  • 2 funds opened new OSR Health Warrant positions in Q3 2024 and 3 closed out, a net change of -1 holder.
  • The largest OSR Health Warrant buyer in Q3 2024 was Cowen and Company, an estimated $15.1K added.
  • The largest OSR Health Warrant seller in Q3 2024 was Mangrove Partners, an estimated $2.2M sold.

Based on aggregated 13F filings for Q3 2024.